首页> 外文期刊>British Journal of Pharmaceutical Research >Antiplasmodial Activity of the Root Extracts of Cochlospermum tinctorium in Mice Experimentally Infected with Clinical Isolates of Plasmodium berghei berghei (NK 65)
【24h】

Antiplasmodial Activity of the Root Extracts of Cochlospermum tinctorium in Mice Experimentally Infected with Clinical Isolates of Plasmodium berghei berghei (NK 65)

机译:感染了伯氏疟原虫(NK 65)的临床分离株实验性感染的天冬菊的根提取物的抗血浆活性

获取原文
           

摘要

Aims: To determine in vivo the antiplasmodial activity of two chromatographic fractions obtained from Cochlospermum tinctorium A. Rich root bark extract against Plasmodium berghei berghei in mice. Methodology: Two chromatographic fractions were obtained from the crude methanolic extract of C. tinctorium root bark using petroleum ether (Fraction 1) and ethanol (Fraction 2) which were tested to determine their antiplasmodial activity in Swiss Albino mice infected with P. berghei berghei. Fraction 1 was administered at dose levels of 50, 100 and 200mg/kg/day, while fraction 2 was administered at dose levels of 25, 50 and 100 mg/kg/day. Chloroquine at 5 mg/kg per day was used as positive control and 0.2 ml normal saline was applied per day as sham. Results: Fraction 1had a percentage antiplasmodial activity of 80.67%, 64.14% and 69.71% for the dose level of 50, 100 and 200 mg/kg respectively. Data shows that fraction 1 treatment was not dose dependent as the lowest dosage of 50 mg/kg/day produced the highest percentage antiplasmodial activity of 80.67%, while 5 mg/kg chloroquine gave 100% cure. The effects of all treatments were significantly different (p0.05) from that of 5 mg/kg chloroquine. The Median survival time post infection for infected mice treated with sham was 11 days, for infected mice treated with 50, 100 and 200mg/kg of fraction 1, the median survival time was 15.5, 15.5 and 19 days respectively, the log-rank (Mantle-Cox) test value of p0.05).There was however no significant difference (p>0.05) in the mean percentage antiplasmodial activity of fraction 2 (65.26%) which was higher than that of fraction 1 (62.90%). Conclusion: C. tinctorium root bark extractpossess antimalarial and anaemia ameliorating properties which validates its use in traditional medicine for the treatment of malaria.
机译:目的:为了确定在体内从得自A. Cochlospermum tinctorium A的两种色谱分离物中的抗血浆活性。富根皮提取物对伯氏疟原虫具有抗药性。方法学:使用石油醚(组分1)和乙醇(组分2)从淡色梭菌根皮的粗甲醇提取物中获得了两个色谱级分,测试了它们的含量,以确定它们在感染了伯氏疟原虫的瑞士白化小鼠中的抗血浆活性。级分1的剂量水平为50、100和200mg / kg /天,而级分2的剂量水平为25、50和100 mg / kg /天。每天以5 mg / kg的氯喹作为阳性对照,每天以0.2 ml生理盐水作假。结果:对于50、100和200 mg / kg的剂量水平,组分1的抗疟原虫活性百分比分别为80.67%,64.14%和69.71%。数据显示,级分1处理不受剂量依赖性,因为最低剂量50 mg / kg /天产生最高的抗血浆活性百分比为80.67%,而5 mg / kg氯喹可100%治愈。所有处理的效果均与5 mg / kg氯喹的效果显着不同(p0.05)。用假手术处理的感染小鼠感染后的中位生存时间为11天,用50、100和200mg / kg级分1处理的感染小鼠的中位生存时间分别为15.5、15.5和19天,对数秩( Mantle-Cox)检验值为p0.05),但级分2的平均抗血浆活性百分比(65.26%)没有显着差异(p> 0.05),高于级分1的平均抗血浆活性百分比(62.90%)。结论:C。tinctorium根皮提取物具有抗疟和改善贫血的特性,这证明其在传统医学中可用于治疗疟疾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号